TSX:HLS (HLS Therapeutics Inc.)
About HLS
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.
HLS Therapeutics Inc. (TSX: HLS) Latest News
Dividend Stocks
2 Top Pharmaceutical Stocks to Buy on the TSX Today
Dividend Stocks
3 Biotech Stocks to Buy Before the Down Market Is Over
Investing
Got $4,000? 4 Cheap Stocks to Buy Right Now
Investing
2 Unstoppable Growth Stocks You Could Buy With Less Than $40
Coronavirus
Is HLS Therapeutics a Can’t-Miss Buy?
Investing
Got $1,000? 3 TSX Stocks to Buy Now
Investing
4 Undervalued Stocks to Buy With Just $500
Cannabis Stocks
Forget Aurora Cannabis: Here Are 2 Pot Stocks You Can Buy Instead!
Energy Stocks
3 Top Canadian Stocks to Buy in July
Investing
17 Top TSX Stock Picks for July 2021
Cannabis Stocks
Want to Play U.S. Cannabis Legalization? Consider This Top Canada-Listed Stock Today
Dividend Stocks
RRSP Investors: 3 Top TSX Stocks to Own in 2021
1❯